Patent · US Active

Methods and compositions for treating carbapenem-resistant klebsiella pneumoniae infections

US12016874B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

CITY UNIVERSITY OF HONG KONG · CN

Inventors

Sheng CHEN · Tongji, CN
Bill Kwan-wai Chan · Hong Kong, CN
Hongyuhang Ni · Hong Kong, CN

Key dates

Filing date	Aug 16, 2022
Grant date	Jun 25, 2024
Priority date	—
Expiry date	Aug 16, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of using rifampicin and zidovudine and pharmaceutical compositions comprising the same to inhibit growth of and/or kill Klebsiella pneumoniae, such as antibiotic-resistant Klebsiella pneumoniae.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.